The GH stack.
The one popular stack whose mechanistic rationale is genuinely well founded, which makes the missing outcome evidence more conspicuous rather than less.
Evidence check · reviewed June 1, 2026
The two compounds act on two different receptors that both raise growth hormone, so combining them is said to produce a larger GH release than either alone.
What the evidence actually shows.
This stack has the strongest mechanistic case of any on this page, and the case is real. GHRH analogs act on the growth hormone releasing hormone receptor. Ghrelin mimetics act on a completely separate receptor, the growth hormone secretagogue receptor. These are independent levers on the same output, and pulling both produces a larger GH release than pulling either alone. That is established pharmacology, not a marketing invention.
The gap is between that pharmacology and any outcome anyone actually wants. Raising growth hormone is a biomarker change. Whether it produces meaningful improvements in body composition, recovery, sleep or anything else in healthy adults is a separate question, and the controlled trials that would answer it for this combination have not been run.
This distinction gets lost constantly. A user who checks IGF-1 and sees it rise has confirmed the stack engaged the pathway it was designed to engage. That is a successful mechanism check and not evidence of benefit. The compounds do what they say on the tin; what remains unproven is that what they do is worth doing.
A pharmacokinetic detail matters for how this stack is discussed. The DAC and non-DAC versions of the GHRH component behave completely differently: one produces sustained elevation over days while the other drives a short discrete pulse. Since natural GH secretion is pulsatile and that pulsatility appears to matter biologically, sustained elevation is a meaningfully different intervention rather than simply a more convenient one.
The mechanism is real and the GH rise is measurable. What has never been demonstrated in controlled trials is that raising GH this way produces the body composition or recovery outcomes people are buying it for.
Working out the concentration math for a multi-compound preparation? The blend calculator handles the per-component arithmetic on numbers you enter. It suggests nothing.
Blend calculator →FAQ.
Do the two really work together?
Yes, at the level of GH release. They act on separate receptors and the combined effect on GH secretion is larger than either alone. That is a pharmacological fact, distinct from any claim about downstream benefit.
DAC or no-DAC?
They are different interventions. The DAC version sustains GH elevation for days; the no-DAC version produces a short pulse closer to the body's natural pattern. Neither has outcome trials behind it for this use.
Does rising IGF-1 mean it is working?
It confirms the compounds engaged the axis. It does not confirm any benefit, because the trials linking that biomarker change to outcomes in healthy adults have not been done.
Cite this page
PepCue. “The GH stack (CJC-1295 + ipamorelin): what the evidence shows.” PepCue, reviewed June 1, 2026. https://www.pepcue.app/stacks/gh-stack.